A Prospective Evaluation of the Filler for Jaw Contouring

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Dermal Fillers
Interventions
DRUG

HA filler

patient will receive FDA approved dosages of filler to the lower face region to treat facial contour or asymmetry, as per FDA approved indications. Patients are limited to 20 mL of any JUVÉDERM® injectable gel per 60 kg (132 lbs) body mass per year. Prior to injection patients will be imaged with 3-dimensional photogrammetry. Subjects will return post-injection in 2 weeks, 1 month, and 3 months for re-imaging.

Trial Locations (1)

19104

Penn Medicine, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER